Common alterations in parallel metabolomic profiling of serum and spinal cord and mechanistic studies on neuropathic pain following PPARα administration
Authors:
- 12 May 2024
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 254, 109988
Abstract
No abstract availableKeywords
Funding Information
- Tianjin Municipal Health Commission
- Tianjin science and technology commission
This publication has 61 references indexed in Scilit:
- NLR family pyrin domain containing 3 (NLRP3) inflammasomes and peripheral neuropathic pain - Emphasis on microRNAs (miRNAs) as important regulatorsEuropean Journal of Pharmacology, 2023
- Advances in regulation and function of stearoyl-CoA desaturase 1 in cancer, from bench to bedScience China Life Sciences, 2023
- Muscle-building supplement β-hydroxy β-methylbutyrate binds to PPARα to improve hippocampal functions in miceCell Reports, 2023
- Molecular mechanisms and therapeutic perspectives of peroxisome proliferator‐activated receptor α agonists in cardiovascular health and diseaseMedicinal Research Reviews, 2023
- The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseasesAgeing Research Reviews, 2023
- PPARα contributes to the therapeutic effect of hydrogen gas against sepsis-associated encephalopathy with the regulation to the CREB-BDNF signaling pathway and hippocampal neuron plasticity-related gene expressionBrain Research Bulletin, 2022
- A Compound Mitigates Cancer Pain and Chemotherapy-Induced Neuropathic Pain by Dually Targeting nNOS-PSD-95 Interaction and GABAA ReceptorNeurotherapeutics, 2021
- Spinal microglia-neuron interactions in chronic painJournal of Leukocyte Biology, 2020
- PPARs and molecular mechanisms of transrepressionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in manPain, 1988